Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Wasserman

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Journal of Food Allergy|September 11, 2024
A diagnostic approach to IgE-mediated food allergy: A practical algorithmRichard L Wasserman
Expert Review of Clinical Immunology|September 4, 2014
Hizentra for the treatment of primary immunodeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 28, 2022
Traveling with primary immunodeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 14, 2022
Immunoglobulin replacement therapy stewardship in modern timesRichard L Wasserman
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2016
The Nuts and Bolts of Immunoglobulin Treatment for Antibody DeficiencyRichard L Wasserman
Immunology and Allergy Clinics of North America|November 24, 2018
Personalized Therapy: Immunoglobulin Replacement for Antibody DeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2025
Remote oral immunotherapy updosing: Access, safety, and economicsRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 11, 2022
Reply to high cost of immunoglobulin replacement therapy: Causes and implicationsRichard L Wasserman
Immunotherapy|September 6, 2017
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseasesRichard L Wasserman
Patient Preference and Adherence|November 19, 2009
Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectationsRichard L Wasserman
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Journal of Food Allergy|September 11, 2024
A diagnostic approach to IgE-mediated food allergy: A practical algorithmRichard L Wasserman
Expert Review of Clinical Immunology|September 4, 2014
Hizentra for the treatment of primary immunodeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 28, 2022
Traveling with primary immunodeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 14, 2022
Immunoglobulin replacement therapy stewardship in modern timesRichard L Wasserman
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2016
The Nuts and Bolts of Immunoglobulin Treatment for Antibody DeficiencyRichard L Wasserman
Immunology and Allergy Clinics of North America|November 24, 2018
Personalized Therapy: Immunoglobulin Replacement for Antibody DeficiencyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2025
Remote oral immunotherapy updosing: Access, safety, and economicsRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 11, 2022
Reply to high cost of immunoglobulin replacement therapy: Causes and implicationsRichard L Wasserman
Immunotherapy|September 6, 2017
Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseasesRichard L Wasserman
Patient Preference and Adherence|November 19, 2009
Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectationsRichard L Wasserman
Pageof 10